1216. Deputy Ken O'Flynn asked the Minister for Health if any dedicated disability, occupational or psychosocial supports exist for persons experiencing long-term complications associated with lyme disease; and if she will make a statement on the matter. [39060/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Disease Management.
230 questions match, newest first.
1217. Deputy Ken O'Flynn asked the Minister for Health if the HSE maintains data on waiting times for infectious disease consultations relating to suspected lyme disease; and if she will make a statement on the matter. [39061/26]
1218. Deputy Ken O'Flynn asked the Minister for Health if a review has been undertaken regarding access to intravenous antibiotic treatment for severe lyme disease cases within the public health system; and if she will make a statement on the matter. [39062/26]
1219. Deputy Ken O'Flynn asked the Minister for Health if her Department funds or supports any Irish research projects relating to lyme disease, tick-borne illnesses, or long-term post-infectious complications; the funding allocated annually since 2020; and if she will make a statement on the matter. [39063/26]
1220. Deputy Ken O'Flynn asked the Minister for Health if lyme disease is included within national communicable disease surveillance and reporting frameworks operated by the HSE and Health Protection Surveillance Centre; and if she will make a statement on the matter. [39064/26]
1221. Deputy Ken O'Flynn asked the Minister for Health the number of hospital admissions annually associated with lyme disease, neurological lyme disease, lyme carditis or lyme arthritis from 2020 to 2026, in tabular form. [39065/26]
1222. Deputy Ken O'Flynn asked the Minister for Health if her Department has assessed the economic and workforce impact associated with long-term lyme disease illness, including inability to work and disability-related impacts; and if she will make a statement on the matter. [39066/26]
365. Deputy Michael Cahill asked the Minister for Health if she will intervene to ensure that the HSE urgently prioritises a conclusion to the skyclarys reimbursement negotiations (details supplied); her views on whether the current delay aligns with the "equitable access" promised in the newly launched National Rare Disease Strategy 2025-2030; and if she will make a statement on the matter. [38593/26]
1195. Deputy Cathal Crowe asked the Minister for Health if she will confirm whether Action 4 of the HSE position paper on FASD Prevention, published in September 2022, namely has now been completed (details supplied); the total cost associated of the campaign; the due diligence that was carried out to ensure any external designers, consultants, advertising agencies or suppliers engaged as part of the campaign have no…
1238. Deputy Pádraig Rice asked the Minister for Health if she will commit to establishing early access schemes for new medicines for the treatment of rare diseases; and if she will make a statement on the matter. [37774/26]
1239. Deputy Pádraig Rice asked the Minister for Health the status of the Programme for Government commitment and National Rare Disease Strategy recommendation to consider early access schemes for rare diseases; the status of these considerations; the work carried out to date; the timeline she is working towards in completing this work; and if she will make a statement on the matter. [37775/26]
785. Deputy John Lahart asked the Minister for Health the progress being made under the Programme for Government in the area of endometriosis; and if she will make a statement on the matter. [36878/26]
1253. Deputy Robert O'Donoghue asked the Minister for Health the current status of the national HIV Action Plan; when her Department expects to publish or update the next phase of this plan; the specific measures being taken to improve access to testing, treatment and prevention services, including PrEP, particularly for high-risk and underserved populations; and if she will make a statement on the matter. [30671/26]
1254. Deputy Robert O'Donoghue asked the Minister for Health her views on whether current sexual health services are sufficient to meet the needs of those at risk of HIV transmission; if she will outline plans to expand HIV prevention, testing and treatment services in light of recent new diagnoses; and if she will make a statement on the matter. [30672/26]
778. Deputy Ken O'Flynn asked the Minister for Health the proportion of cases of type 2 diabetes and cardiovascular disease that are attributable to obesity in Ireland; the annual treatment cost to the HSE for these obesity-related conditions; the estimated share of total healthcare expenditure linked to obesity-related disease; and if she will make a statement on the matter. [28095/26]
779. Deputy Ken O'Flynn asked the Minister for Health the estimated annual cost to the HSE of treating obesity and obesity-related conditions between 2020 to date; the breakdown of this cost, across hospital care, primary care, pharmaceuticals and community services, in tabular form; and if she will make a statement on the matter. [28096/26]
780. Deputy Ken O'Flynn asked the Minister for Health if her Department or the HSE has projected the cost to the health service over the next ten years if obesity prevalence continues to rise; and if she will make a statement on the matter. [28097/26]
783. Deputy Ken O'Flynn asked the Minister for Health the regional prevalence of obesity in Ireland; the regions with the highest hospital admission rates for obesity-related illness; the steps being taken to address health inequalities linked to obesity; and if she will make a statement on the matter. [28100/26]
2612. Deputy Emer Currie asked the Minister for Health the actions her Department is taking following the meningitis outbreak in the UK; and if she will make a statement on the matter. [23550/26]
2789. Deputy Denise Mitchell asked the Minister for Health if consideration will be given to adding Crohn’s disease to the long term illness scheme in order that those suffering with this chronic lifelong condition can avail of medicines and treatments to manage their disease; and if she will make a statement on the matter. [24279/26]
2797. Deputy David Cullinane asked the Minister for Health if her attention has been drawn to the barriers currently faced by patients in Ireland living with lipoedema (details supplied); the steps her Department and the HSE are taking to address these issues; and if she will make a statement on the matter. [24297/26]
2798. Deputy David Cullinane asked the Minister for Health whether the HSE working group established in 2023 to develop a national care pathway for lipoedema has completed its work; when the pathway is expected to be published; and whether patient advocacy organisations, including an organisation (details supplied) will be included in the development and implementation of this pathway. [24298/26]
2799. Deputy David Cullinane asked the Minister for Health if her Department intends to review the operation of private health insurers in relation to coverage for medically indicated liposuction procedures for lipoedema patients, in light of concerns regarding inconsistent decision-making, the use of criteria designed for lymphoedema rather than lipoedema, and practices that may result in patients being forced to re…
2826. Deputy Roderic O'Gorman asked the Minister for Health the priority being given to projects to support sufferers of lymphoedema within the HSE; whether consideration will be given to support free compression leggings every three months as is recommended and accelerated delivery of programmes to help drainage; and if she will make a statement on the matter. [24434/26]
2851. Deputy Sinéad Gibney asked the Minister for Health if she is aware of the barriers currently faced by patients in Ireland living with lipoedema, including the absence of a published national HSE care pathway, limited access to conservative management such as compression therapy and manual lymphatic drainage, and delays or difficulties accessing treatment through the Cross Border Healthcare Directive; the steps …